| Literature DB >> 27856699 |
Amy R Ellison1, Graziella V DiRenzo2, Caitlin A McDonald3, Karen R Lips2, Kelly R Zamudio3.
Abstract
For generalist pathogens, host species represent distinct selective environments, providing unique challenges for resource acquisition and defense from host immunity, potentially resulting in host-dependent differences in pathogen fitness. Gene expression modulation should be advantageous, responding optimally to a given host and mitigating the costs of generalism. Batrachochytrium dendrobatidis (Bd), a fungal pathogen of amphibians, shows variability in pathogenicity among isolates, and within-strain virulence changes rapidly during serial passages through artificial culture. For the first time, we characterize the transcriptomic profile of Bd in vivo, using laser-capture microdissection. Comparison of Bd transcriptomes (strain JEL423) in culture and in two hosts (Atelopus zeteki and Hylomantis lemur), reveals >2000 differentially expressed genes that likely include key Bd defense and host exploitation mechanisms. Variation in Bd transcriptomes from different amphibian hosts demonstrates shifts in pathogen resource allocation. Furthermore, expressed genotype variant frequencies of Bd populations differ between culture and amphibian skin, and among host species, revealing potential mechanisms underlying rapid changes in virulence and the possibility that amphibian community composition shapes Bd evolutionary trajectories. Our results provide new insights into how changes in gene expression and infecting population genotypes can be key to the success of a generalist fungal pathogen.Entities:
Keywords: Batrachochytrium dendrobatidis; gene expression; laser capture microdissection; pathogen; transcriptomics
Mesh:
Year: 2017 PMID: 27856699 PMCID: PMC5217115 DOI: 10.1534/g3.116.035873
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Summary of sample infection loads, read mapping, and Bd gene detection
| ID | Host | No. Mapped Reads (M) | % Mapped Read | No. | % | ||
|---|---|---|---|---|---|---|---|
| Bd | Host | ||||||
| C1 | Culture | — | 19.85 | 100.00 | — | 7782 | 94.12 |
| C2 | Culture | — | 15.54 | 100.00 | — | 7763 | 93.89 |
| C3 | Culture | — | 19.70 | 100.00 | — | 7766 | 93.93 |
| C4 | Culture | — | 18.18 | 100.00 | — | 7791 | 94.23 |
| AZ1 | 89.62 | 48.19 | 34.65 | 65.35 | 7315 | 88.47 | |
| AZ2 | 23.44 | 35.73 | 39.90 | 60.10 | 7932 | 95.94 | |
| AZ3 | 174.75 | 23.66 | 24.79 | 75.21 | 7823 | 94.62 | |
| AZ4 | 44.77 | 65.01 | 12.69 | 87.31 | 7678 | 92.86 | |
| HL1 | 20.95 | 59.28 | 8.15 | 91.85 | 7243 | 87.60 | |
| HL2 | 11.09 | 52.48 | 6.70 | 93.30 | 7329 | 88.64 | |
| HL3 | 122.68 | 44.77 | 4.03 | 95.97 | 6284 | 76.00 | |
| Total | — | — | — | — | 8268 | 100.00 | |
K ZGE, thousand zoospore genomic equivalents.
Figure 1Heatmap of sample differences in gene expression. Based on hierarchical clustering of Poisson distances of Bd gene expression values. Color intensity indicates distance; darker blue equates to more similar samples. Sample letters indicate Bd treatment; C = agar culture plate, AZ = A. zeteki, and HL = H. lemur.
GO terms of genes found to be differentially expressed by Bd in culture and frog hosts
| GO ID | GO Term | Category | FDR P-Value |
|---|---|---|---|
| Increased expression in both frog species | |||
| GO:0008236 | Serine-type peptidase activity | F | 4.07E–05 |
| GO:0017171 | Serine hydrolase activity | F | 4.07E–05 |
| GO:0015171 | Amino acid transmembrane transporter activity | F | 2.89E–03 |
| GO:0070011 | Peptidase activity, acting on L-amino acid peptides | F | 4.09E–03 |
| GO:0008233 | Peptidase activity | F | 4.96E–03 |
| GO:0008061 | Chitin binding | F | 5.36E–03 |
| GO:0046943 | Carboxylic acid transmembrane transporter activity | F | 6.87E–03 |
| GO:0005342 | Organic acid transmembrane transporter activity | F | 6.87E–03 |
| GO:0008514 | Organic anion transmembrane transporter activity | F | 4.45E–02 |
| GO:0004806 | Triglyceride lipase activity | F | 4.45E–02 |
| GO:0003824 | Catalytic activity | F | 4.60E–02 |
| GO:0006865 | Amino acid transport | P | 2.89E–03 |
| GO:0003333 | Amino acid transmembrane transport | P | 2.89E–03 |
| GO:0098656 | Anion transmembrane transport | P | 4.04E–03 |
| GO:0006508 | Proteolysis | P | 4.09E–03 |
| GO:0015849 | Organic acid transport | P | 3.17E–02 |
| GO:0046942 | Carboxylic acid transport | P | 3.17E–02 |
| GO:0055085 | Transmembrane transport | P | 3.90E–02 |
| Decreased expression in both frog species | |||
| GO:0004674 | Protein serine/threonine kinase activity | F | 1.89E–02 |
| GO:0043167 | Ion binding | F | 1.89E–02 |
| GO:0004672 | Protein kinase activity | F | 1.89E–02 |
| GO:0003700 | Sequence-specific DNA binding transcription factor activity | F | 1.89E–02 |
| GO:0001071 | Nucleic acid binding transcription factor activity | F | 1.89E–02 |
| GO:0005488 | Binding | F | 3.26E–02 |
| GO:0097159 | Organic cyclic compound binding | F | 4.57E–02 |
| GO:1901363 | Heterocyclic compound binding | F | 4.57E–02 |
| GO:0006468 | Protein phosphorylation | P | 1.89E–02 |
| GO:0009069 | Serine family amino acid metabolic process | P | 3.86E–02 |
F, molecular function, P, biological process.
GO terms of genes found to be differentially expressed by Bd in the two frog host species
| GO ID | GO Term | Category | FDR P-Value |
|---|---|---|---|
| Increased expression in | |||
| GO:0003735 | Structural constituent of ribosome | F | 6.21E–07 |
| GO:0005198 | Structural molecule activity | F | 1.41E–05 |
| GO:0009058 | Biosynthetic process | P | 5.68E–09 |
| GO:0044249 | Cellular biosynthetic process | P | 6.49E–09 |
| GO:1901576 | Organic substance biosynthetic process | P | 6.85E–09 |
| GO:0006412 | Translation | P | 4.23E–06 |
| GO:0044237 | Cellular metabolic process | P | 5.31E–05 |
| GO:0042254 | Ribosome biogenesis | P | 2.41E–04 |
| GO:0071704 | Organic substance metabolic process | P | 2.74E–04 |
| GO:0044238 | Primary metabolic process | P | 7.60E–04 |
| GO:0022613 | Ribonucleoprotein complex biogenesis | P | 8.06E–04 |
| GO:0044711 | Single-organism biosynthetic process | P | 1.14E–03 |
| GO:0034645 | Cellular macromolecule biosynthetic process | P | 2.95E–03 |
| GO:0009059 | Macromolecule biosynthetic process | P | 3.62E–03 |
| GO:0009987 | Cellular process | P | 5.08E–03 |
| GO:0044267 | Cellular protein metabolic process | P | 7.05E–03 |
| GO:0006573 | Valine metabolic process | P | 1.52E–02 |
| GO:0006551 | Leucine metabolic process | P | 1.52E–02 |
| GO:0044085 | Cellular component biogenesis | P | 1.57E–02 |
| GO:0008152 | Metabolic process | P | 2.48E–02 |
| GO:0019538 | Protein metabolic process | P | 2.48E–02 |
| GO:0006554 | Lysine catabolic process | P | 2.74E–02 |
| GO:0009068 | Aspartate family amino acid catabolic process | P | 2.74E–02 |
| GO:1901566 | Organonitrogen compound biosynthetic process | P | 2.75E–02 |
| GO:0032787 | Monocarboxylic acid metabolic process | P | 2.75E–02 |
| GO:0006414 | Translational elongation | P | 2.75E–02 |
| GO:0018874 | Benzoate metabolic process | P | 3.03E–02 |
| GO:0006549 | Isoleucine metabolic process | P | 3.36E–02 |
| GO:0006574 | Valine catabolic process | P | 3.36E–02 |
| GO:0006552 | Leucine catabolic process | P | 3.36E–02 |
| GO:0006550 | Isoleucine catabolic process | P | 3.36E–02 |
| GO:0044282 | Small molecule catabolic process | P | 3.86E–02 |
| GO:0006082 | Organic acid metabolic process | P | 4.21E–02 |
| GO:0009083 | Branched-chain amino acid catabolic process | P | 4.31E–02 |
| GO:0009081 | Branched-chain amino acid metabolic process | P | 4.45E–02 |
| GO:0044283 | Small molecule biosynthetic process | P | 4.87E–02 |
| Increased expression in | |||
| GO:0005515 | Protein binding | F | 2.06E–03 |
| GO:0044782 | Cilium organization | P | 4.21E–05 |
| GO:0060271 | Cilium morphogenesis | P | 1.31E–04 |
| GO:0042384 | Cilium assembly | P | 6.31E–04 |
| GO:0010927 | Cellular component assembly involved in morphogenesis | P | 1.68E–03 |
| GO:0030031 | Cell projection assembly | P | 1.68E–03 |
| GO:0032990 | Cell part morphogenesis | P | 2.42E–03 |
| GO:0048858 | Cell projection morphogenesis | P | 2.42E–03 |
| GO:0030030 | Cell projection organization | P | 2.42E–03 |
| GO:0048646 | Anatomical structure formation involved in morphogenesis | P | 8.69E–03 |
| GO:0070925 | Organelle assembly | P | 8.69E–03 |
| GO:0000902 | Cell morphogenesis | P | 2.16E–02 |
| GO:0007224 | Smoothened signaling pathway | P | 2.17E–02 |
| GO:0032989 | Cellular component morphogenesis | P | 2.73E–02 |
F, molecular function; P, biological process.
Figure 2Separation of samples by eSNV frequencies. Principal component analysis of minor allele eSNV frequencies of Bd. Based on eSNVs with minor allele frequency (MAF) >0.1, minimum count = 6, minimum coverage = 20 (31,053 SNVs). (B) Depicts an enlarged area of (A).